dual PI3K delta/gamma inhibitors (Aurigene)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedual PI3K delta/gamma inhibitors (Aurigene)
Drug Alias Nameenzyme inhibitor (Aurigene)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase gamma inhibitorsPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol-4,5-Bisphosphate 3 kinase gammaPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAurigene Oncology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAurigene Oncology Ltd
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A